Latest Rram News

dorsaVi is pivoting from wearable sensors to powering next-gen exoskeletons, leveraging its neuromorphic RRAM technology to tap a projected $2 billion market by 2033.

dorsaVi has confirmed that its proprietary RRAM memory technology and neuromorphic IP portfolio work seamlessly together, projecting a tenfold boost in performance for robotics and exoskeleton applications. This breakthrough lays the groundwork for smarter, faster, and more energy-efficient wearable and robotic devices operating at the ultra-edge.

dorsaVi has commenced development of Sensor V6.5, a firmware upgrade that embeds intelligence directly within its wearable sensors, reducing latency and paving the way for future neuromorphic computing integration.

dorsaVi has secured significant commercial and clinical milestones with new elite sports and European clinical partnerships, showcasing its advanced real-time AI sensor technology.

dorsaVi has initiated early-stage evaluation of resistive RAM (RRAM) test chips, marking a key step toward an advanced 22-nm memory platform designed to meet rising AI-driven demands in edge computing.

dorsaVi has formed a world-class Technical Advisory Board to accelerate its pioneering ‘Intelligence at the Ultra Edge’ strategy, integrating advanced memory and neuromorphic computing into robotics and healthcare devices.

dorsaVi reports strong US commercial growth with over 100 new physical therapy sites and a 50% rise in cash receipts, alongside a strategic leadership change and breakthrough neuromorphic technology acquisition.

dorsaVi has launched a multi-year collaboration with leading Asian research institutes to develop its proprietary RRAM technology at the 22-nanometer node, targeting AI-driven robotics and wearable applications.

DorsaVi reports significant progress in its resistive RAM (RRAM) development, optimizing memory technology for integration with neuromorphic computing at the 22nm technology node. This advancement positions the company to deliver energy-efficient edge-AI solutions for wearables, robotics, and industrial safety.

dorsaVi has launched an evaluation program to scale its oxide-based RRAM technology from 40 nm to 22 nm, aiming for significant gains in density, speed, and energy efficiency. This move could enhance its wearable sensor devices and embedded AI applications.

dorsaVi reports breakthrough RRAM sensor performance and secures a major US physical therapy deal, backed by a $5 million capital raise and new leadership appointments.

dorsaVi reports a striking 15-fold increase in US Physical Therapy clinic subscriptions for its ViMove+ product, driven by strong surgeon endorsements and a successful face-to-face training rollout.